Share
The Endocrine Society is pleased to announce its Rare Endocrine Disease (RED) Fellows Program, a series designed to equip early-career physicians with the knowledge and practical skills needed to improve outcomes for people living with rare endocrine diseases. The program was developed in partnership with the National Organization for Rare Disorders (NORD) and addresses critical gaps in awareness, diagnosis and care of rare endocrine diseases. The program consists of two core components: The program accepts up...
Share
The Endocrine Society is proud of its many distinguished members who lead the global endocrine community by advancing scientific knowledge, providing exemplary care, teaching the next generation of endocrinologists, and improving human health worldwide. For more than 80 years, the Society has recognized the achievements of its members with the annual Laurate Awards. Established in...
Share
The Endocrine Society and The European Society of Endocrinology (ESE) are delighted to announce Anna Gloyn, DPhil, FMedSci, as the winner of the fifth annual Transatlantic Alliance Award. The Transatlantic Alliance Award, launched in 2022, recognizes an international leader who has made significant advancements in endocrine research on both sides of the Atlantic — in Europe and the United States. Gloyn has...
Share
The Endocrine Society today announced it has chosen 12 leading endocrinologists as winners of its prestigious 2026 Laureate Awards, the top honors in the field. These professionals have achieved breakthroughs in scientific discoveries and clinical care benefiting people with hundreds of conditions, including diabetes, thyroid disorders, obesity, hormone-related cancers, growth problems, osteoporosis and infertility. Established...
Share
Many primary aldosteronism cases remain undiagnosed and untreated Endocrine Society experts encouraged more widespread screening for a common hormonal cause of high blood pressure known as primary aldosteronism in a new Clinical Practice Guideline released today. “Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline” was published online and is being presented at ENDO 2025, the...
Share
Scientific Statement aims to expand our research to advance the understanding of the cause and progression of type 1 diabetes. A new Scientific Statement released today by the Endocrine Society highlights potential research directions related to the pathogenesis of type 1 diabetes that should help with the development of new and improved treatment options. ...
Share
As experts dedicated to providing patients with compassionate, evidence-based care every day, we are disappointed in the United States v. Skrmetti decision, which increases the likelihood that other states will limit or eliminate families’ and patients’ ability to access medical care. As doctors, nurse practitioners, and nurses, we believe that every patient is different. Decisions...
Share
Endocrine Society champions resolution passed by House of Delegates On June 10, the American Medical Association (AMA) House of Delegates passed the Endocrine Society’s resolution to improve access to anti-obesity medications. In the resolution, the AMA committed to advocating for reducing the burden of prior authorization, when healthcare providers must seek insurance plan approval before...
